MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
MicroTransponder has raised $65.0M in total funding. The most recent round was Series F. The last funding was announced in March 2025.
MicroTransponder's investors include U.S. Venture Partners, Longitude Capital, OUP (Osage University Partners), Gilde Healthcare, Action Potential Venture Capital.
MicroTransponder is headquartered in Dallas, United States.
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
MicroTransponder is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MicroTransponder — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/microtransponder. Accessed October 28, 2026.
VCBacked. (2025). MicroTransponder — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/microtransponder
{{cite web |title=MicroTransponder — Funding & Investors |url=https://www.vcbacked.co/company/microtransponder |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated